News Sentiment

CCCC sentiment intelligence

C4 Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 37 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.06 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

87/100 classification confidence.

Company focus 29

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-5.6% over one week, +4.1% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

C4 Therapeutics (NASDAQ: CCCC) CMO gains shares via RSU vesting, withholds some for taxes

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 87/100 classification
One-week reaction -5.6% Price reacting lower
Trend fit Trend active 4.1% over four weeks
Fair value 8.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 28
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 29
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
Stock Titan 12
simplywall.st 5
GlobeNewswire 2
MT Newswires 1
Investing News Network 1
Investing.com 1
TradingView 1

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 9
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 37